| Application no. and date | 24150762.3 (espacenet) (Federated) (European Patent Register), 20170909 | | Patent/reg. no. and date | DK/EP 4339615, 20251105 | | Publication date | 20240320 | | Priority no. and date | US 201662395832 P, 20160916, US 201762519590 P, 20170614 | | EP pub. no. and date |
EP 4339615 20240320 | | Effective date | | | Applicant/owner | Shanghai Henlius Biotech, Inc., Room 303, 304, Block 7
No. 1999 Zhangheng Road
Pilot Free Trade Zone
Shanghai, CN | | Applicant ref. no. | | | Inventor | JIANG, Weidong,
Shanghai, CN,
LIN, Pei-Hua,
Shanghai, CN,
TSENG, Chi-Ling,
Shanghai, CN | | Representative | Bergenstråhle & Partners AB, Box 17704, 118 93 Stockholm, SE | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61K 47/68 (2017.01) , A61K 49/16 (2006.01) , A61K 51/10 (2006.01) , A61P 35/00 (2006.01) , C07K 16/18 (2006.01) , C07K 16/22 (2006.01) , C07K 16/28 (2006.01) , C12P 21/08 (2006.01) | | Title | Anti-PD-1-antistof til anvendelse i behandlingen af kræft | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | CA 2026 00006 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
